145 related articles for article (PubMed ID: 32546973)
1. A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers.
Kang WY; Lee HW; Gwon MR; Cho S; Shim WS; Lee KT; Yang DH; Seong SJ; Yoon YR
Drug Des Devel Ther; 2020; 14():2101-2111. PubMed ID: 32546973
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.
Lee J; Rhee SJ; Lee S; Yu KS
Drug Des Devel Ther; 2018; 12():787-794. PubMed ID: 29670335
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic drug interaction study using fimasartan and rosuvastatin in healthy volunteers.
Kang WY; Kim EH; Seong SJ; Gwon MR; Yang DH; Kim HJ; Lim MS; Lee HW; Yoon YR
Int J Clin Pharmacol Ther; 2016 Dec; 54(12):992-1003. PubMed ID: 27668695
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers.
Yi S; Kim TE; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
J Cardiovasc Pharmacol; 2011 Jun; 57(6):682-9. PubMed ID: 21394036
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Cho S; Shim WS; Lee KT; Kim EH; Yang DH; Lee HW; Yoon YR
Drug Des Devel Ther; 2018; 12():3607-3615. PubMed ID: 30464392
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.
Oh M; Ghim JL; Park SE; Kim EY; Shin JG
Drug Des Devel Ther; 2018; 12():1157-1164. PubMed ID: 29780236
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets.
Hwang JG; Yu KS; Lee S
Drug Des Devel Ther; 2020; 14():1953-1961. PubMed ID: 32546962
[TBL] [Abstract][Full Text] [Related]
8. Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study.
Kim S; Lee J; Shin D; Lim KS; Kim YS; Jang IJ; Yu KS
Drug Des Devel Ther; 2014; 8():1723-31. PubMed ID: 25336916
[TBL] [Abstract][Full Text] [Related]
9. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the drug-drug interactions between fimasartan and hydrochlorothiazide in healthy volunteers.
Jeon H; Lim KS; Shin KH; Kim J; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
J Cardiovasc Pharmacol; 2012 Jan; 59(1):84-91. PubMed ID: 21934629
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers.
Choi Y; Lee S; Jang IJ; Yu KS
Drug Des Devel Ther; 2018; 12():2301-2309. PubMed ID: 30087555
[TBL] [Abstract][Full Text] [Related]
12. The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan.
Gu N; Cho JY; Shin KH; Jang IJ; Rhee MY
Drug Des Devel Ther; 2016; 10():1525-31. PubMed ID: 27143858
[TBL] [Abstract][Full Text] [Related]
13. Effect of multiple doses of fimasartan, an angiotensin II receptor antagonist, on the steady-state pharmacokinetics of digoxin in healthy volunteers.
Yi S; Kim JW; Kim TE; Kim J; Jun YK; Choi J; Yoon SH; Cho JY; Song SH; Shin SG; Jang IJ; Yu KS
Int J Clin Pharmacol Ther; 2011 May; 49(5):321-7. PubMed ID: 21543035
[TBL] [Abstract][Full Text] [Related]
14. The effect of the newly developed angiotensin receptor II antagonist fimasartan on the pharmacokinetics of atorvastatin in relation to OATP1B1 in healthy male volunteers.
Shin KH; Kim TE; Kim SE; Lee MG; Song IS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
J Cardiovasc Pharmacol; 2011 Nov; 58(5):492-9. PubMed ID: 21765368
[TBL] [Abstract][Full Text] [Related]
15. Absolute bioavailability and pharmacokinetics of the angiotensin II receptor antagonist fimasartan in healthy subjects.
Ghim JL; Paik SH; Hasanuzzaman M; Chi YH; Choi HK; Kim DH; Shin JG
J Clin Pharmacol; 2016 May; 56(5):576-80. PubMed ID: 26272450
[TBL] [Abstract][Full Text] [Related]
16. The effect of fimasartan, an angiotensin receptor type 1 blocker, on the pharmacokinetics and pharmacodynamics of warfarin in healthy Korean male volunteers: a one-sequence, two-period crossover clinical trial.
Gu N; Kim BH; Lim KS; Kim SE; Nam WS; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2012 Jul; 34(7):1592-600. PubMed ID: 22727611
[TBL] [Abstract][Full Text] [Related]
17. Increased systemic exposure of fimasartan, an angiotensin II receptor antagonist, by ketoconazole and rifampicin.
Kim JW; Yi S; Kim TE; Lim KS; Yoon SH; Cho JY; Lee MG; Song IS; Shin SG; Jang IJ; Yu KS
J Clin Pharmacol; 2013 Jan; 53(1):75-81. PubMed ID: 23400746
[TBL] [Abstract][Full Text] [Related]
18. Influence of hepatic dysfunction on the pharmacokinetics and safety of fimasartan.
Kim CO; Lee HW; Oh ES; Seong SJ; Kim DY; Lee J; Ahn SH; Yoon YR; Cho CM; Park MS
J Cardiovasc Pharmacol; 2013 Dec; 62(6):524-9. PubMed ID: 24084213
[TBL] [Abstract][Full Text] [Related]
19. Phase 1 and Pharmacokinetic Drug-Drug Interaction Study of Metformin, Losartan, and Linagliptin Coadministered With DW1029M in Healthy Volunteers.
Moon SJ; Kim SY; Lim CH; Jang HB; Kim MG; Jeon JY
Clin Pharmacol Drug Dev; 2017 Jul; 6(4):408-419. PubMed ID: 27739231
[TBL] [Abstract][Full Text] [Related]
20. Effect of age on the pharmacokinetics of fimasartan (BR-A-657).
Lee HW; Lim MS; Seong SJ; Lee J; Park J; Seo JJ; Cho JY; Yu KS; Yoon YR
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1337-44. PubMed ID: 21950382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
